Meta-analysis of the relationship between the Metholenetetrahydrofolate reductase C677T genetic polymorphism, folate intake and esophageal cancer

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 1, 2011, Pages 247-252

  Liu, Yi Xia ^a   Wang, Bin ^b   Wan, Mei Hua ^a   Tang, Wen Fu ^a   Huang, Fu Kai ^b   Li, Chengwen ^a  

^a SICHUAN UNIVERSITY   (China)

^b Beijing Tibetan and Ethnic Medicine Hospital   (China)

Author keywords

Esophageal cancer; Folate intake; Meta analysis; Methylenetetrahydrofolate reductase C677T

Indexed keywords

EID: 79958751977     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Aune D, Deneo-Pellegrini H, Ronco AL, et al . (2011). Dietary folate intake and the risk of 11 types of cancer: a case-control study in Uruguay. Ann Oncol,, 444-51.
2. Bailey LB, Gregory JF 3rd . (1999). Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, isks and impact on folate requirement. J Nutr, 129, 919-22.
3. Blount BC, Mack MM, Wehr CM, et al . (2007). Folate deficiencychromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A, 94, 3290-5.
4. Chen H, Tucker KL, Graubard BI, et al . (2002). Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr ancer, 42, 33-40.
5. Chen J, Goovannucci E, Kelsey K, et al . (1996). A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res, 56, 4862-4.
6. Chen Y, Deng YC, A He-li, et al . (2009). Relationship between MTHFR gene polymorphisms and susceptibility of esophageal cancer of Han nationality in Xinjiang. J Toxicol, 23, 429-32.
7. Choi SW, Mason JB . (2000). Folate and carcinogenesis: an integrated scheme. J Nutr, 130, 129-32.
8. Feng C, Gao S, Xin HE, et al . (2006). Analysis ofmethylenetetrahydrofolate reductase and thymidylate synthase gene polymorphisms of esophageal and cardia cancerpatients. J Zhengzhou University Med Sci, 41, 10-4.
9. Galeone C, Pelucchi C, Levi F, et al . (2006). Folate intake and squamous-cell carcinoma of the oesophagus in Italian and Swiss men. Ann Oncol, 17, 521-5.
10. Gao C, Wu J, Ding J, et al . (2002). Polymorphisms of methylenetetrahydrofolate reductase C677T and the risk of stomach cancer. Zhonghua Liu Xing Bing Xue Za Zhi, 23, 289-92.
11. Graziano F, Kawakami K, Ruzzo A, et al . (2006). Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population. Int J Cancer, 118, 628-32.
12. He Y, Zhang J, Li Y, et al . (2007). Correlation between a polymorphism in the methylene tetrahydrofolate reductase gene and susceptibility to carcinoma of the esophagus and gastric cardia. Chinese J Clin Oncol, 34, 194-7.
13. Ibiebele TI, Hughes MC, Pandeya N, et al . (2011). High intake of folate from food sources is associated with reduced risk of esophageal cancer in an Australian population. J Nutr, 141, 274-83.
14. Kim YI . (2004). Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev, 13, 511-9.
15. Kureshi N, Ghaffar S, Siddiqui S, et al . (2004). Head and neck cancer susceptibility: a genetic marker in the methylenetetrahydrofolate reductase gene. ORL J Otorhinolaryngol Relat Spec, 66, 241-5.
16. Larsson SC, Giovannucci E, Wolk A, . (2006). Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: ameta-analysis. Gastroenterology, 131, 1271-83.
17. Li D, Diao Y, Li H, et al . (2008). Association of the polymorphisms of MTHFR C677T, VDR C352T, and MPO G463A with risk for esophageal squamous cell dysplasia and carcinoma. Arch Med Res, 39, 594-600.
18. Ma J, Stampfer MJ, Giovannucci E, et al . (1997). Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of olorectal cancer. Cancer Res, 57, 1098-102.
19. Mayne ST, Risch HA, Dubrow R, et al . (2001). Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev, 10, 1055-62.
20. Miao X, Xing D, Tan W, et al . (2002). Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk Chinese population. Cancer Epidemiol Biomarkers Prev, 11, 1454-8.
21. Parkin DM, Bray F, et al . (2005). Global cancer statistics 2002. CA Cancer J Clin, 55, 74-108.
22. Qin JM, Yang L, Chen B, et al . (2008). Interaction of methylenetetrahydrofolate reductase C677T, cytochrome P4502E1 polymorphism and environment factors in esophageal cancer in Kazakh population. World J Gastroenterol, 14, 6986-92.
23. Song C, Xing D, Tan W, et al . (2001). Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res, 61, 327-5.
24. Stern JAC BM, Egger M . (2001). Meta-analysis in STATA., 2nd edn. London: BMJ Publishing; 2001.
25. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, et al . (2003). Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev, 12, 1222-6.
26. Vizcaino AP, Moreno V, Lambert R, et al . (2002). Time trends incidence of both major histologic types of esophageal carcinomas in selected countries 1973-1995. Int J Cancer, 99, 860-8.
27. Wang LD, Guo RF, Fan ZM, et al . (2005). Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus, 18, 177-84.
28. Wang Q, Li D, Yew EJ, et al . (2009).Effect of MTHFR C677T mutation, interaction between MTHFR C677T mutation and environm ental factors on esophageal cancer. Chinese J Public Hlth, 25, 1308-10.
29. Wang Y, Guo W, He Y, et al . (2007). Association of MTHFR C677T and SHMT(1) C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China. Cancer Causes Control, 18, 143-52.
30. Wu D, Cederbaum AI . (2003). Alcohol, oxidative stress, and free radical damage. Alcohol Res Health, 27, 277-84.
31. Wu JZ, Ding JH, Liu YT, et al . (2002). Polymorphisms of methylenetetrahydrofolate reductase C677T and the risk of esophageal cancer. Tumor, 22, 268-70.
32. Yang CX, Matsuo K, Ito H, et al . (2005). Gene-environment interactions between alcohol drinking and the MTHFR C677T polymorphism impact on esophageal cancer risk: results of a case-control study in Japan. Carcinogenesis, 26, 1285-90.
33. Zhang JH, Guo Y, Wang R, et al . (2003). The association of methylenetetrahydrofolate reductase C677T polymorphism and esophageal squamous cell carcinoma analyzed by lightcycler. Prog Biochem Biophys, 30, 555-9.
34. Zhang JH, Pang LJ, Zhao J, et al . (2006). Relationship between polymorphism of methylenetetrahydrofolate reductase C677T and Kazakh's esophageal squamous cell cancer in Xingjiang. J Shihezi University(Natural Science), 24, 138-41.
35. Zhang JH, Zotz RB, Li Y, et al . (2004). Methylenetetrahydrofolate reductase C677T polymorphism and predisposition towards esophageal squamouscell carcinoma in a German Caucasian and a northern Chinese population. J Cancer Res Clin Oncol, 130, 574-80.